Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients.

For the vast number of subsets, the difference in patient survival between the subgroups remained significant or stayed close to the level of significance obtained for the full data set, although p-values of the log-rank tests increased with increasing number of excluded patients (Fig. 1 C).

also in 96 other papers